Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Aurinia Pharm Ord (NQ: AUPH ) 7.210 -0.150 (-2.04%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Aurinia Pharm Ord < Previous 1 2 3 4 5 6 Next > AUPH Stock Earnings: Aurinia Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024 May 02, 2024 AUPH stock results show that Aurinia Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Analog Devices To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday February 22, 2024 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Via Benzinga Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day Session February 15, 2024 Shares of Herbalife Ltd. (NYSE: HLF) fell sharply in today’s session following weak quarterly earnings. Via Benzinga Earnings Scheduled For February 15, 2024 February 15, 2024 Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million. Via Benzinga Earnings Outlook For Aurinia Pharmaceuticals February 14, 2024 Via Benzinga Aurinia Pharmaceuticals Finds No Buyer After Strategic Business Review, Launches Stock Buyback February 15, 2024 Aurinia Pharmaceuticals Q4 2023 results: EPS loss $(0.19), sales $45.1 million. AUR200 development halted. Strategic review concludes. $150 million share buyback initiated. Via Benzinga What's Going On With Aurinia Pharmaceuticals Stock? January 05, 2024 Aurinia Pharmaceuticals, Inc. (NASDAQ: AUPH) shares are trending on social media Friday. The company provided its preliminary, unaudited fourth-quarter and fiscal year 2023 financial results. What To... Via Benzinga What's Going On With Aurinia Pharmaceuticals Stock? November 20, 2023 Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares are trading higher, adding to gains of more than 17% over the last week. Via Benzinga This Oil Giant Is 'Not Great, Not Bad,' But Jim Cramer Says 'I'm Sticking With My Coterra' October 30, 2023 On CNBC’s "Mad Money Lightning Round," Jim Cramer said BP (NYSE: BP) is "not great, not bad." He added, "This whole group is going through a real re-evaluation. Via Benzinga Why Aurinia Pharmaceuticals Stock Is Slumping Today September 18, 2023 The biotech's premium valuation doesn't seem to be sitting well with investors. Via The Motley Fool Aurinia Pharmaceuticals Earnings Perspective: Return On Capital Employed May 18, 2023 Via Benzinga Aurinia Pharmaceuticals: Q1 Earnings Insights May 04, 2023 Via Benzinga Why Aurinia Pharmaceuticals Stock Is Glowing Green Today April 11, 2023 Investors appear to be cheering another patent win by the company. Via The Motley Fool Aurinia Pharmaceuticals's Return On Capital Employed Insights March 03, 2023 Via Benzinga Why Aurinia Pharmaceuticals Stock Is Marching Higher Friday June 30, 2023 The biotech's board is exploring strategic alternatives to boost shareholder value. Via The Motley Fool Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday's Mid-Day Session June 30, 2023 Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top... Via Benzinga Carnival, SMART Global, Friedman Industries And Other Big Stocks Moving Higher On Friday June 30, 2023 U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording gains in today’s session. Via Benzinga Preview: Aurinia Pharmaceuticals's Earnings February 27, 2023 Via Benzinga Aurinia Surges As It Explores 'Strategic Alternatives,' Including A Potential Buyout June 30, 2023 The company makes a lupus nephritis treatment that could easily bolt onto a suitor, analysts say. Via Investor's Business Daily Why Are Aurinia Pharmaceuticals Shares Trading Higher Today June 30, 2023 Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) initiated an exploration of strategic alternatives, including a potential sale, merger, or Via Benzinga Why Renalytix Are Trading Higher By Over 48%; Here Are 20 Stocks Moving Premarket June 30, 2023 Gainers Renalytix Plc (NASDAQ: RNLX) shares surged 48.7% to $3.02 in pre-market trading after the company received FDA De Novo marketing authorization for its KidneyIntelX.dkd prognostic test. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday June 30, 2023 It's the final day of trading this week and we're starting off with a breakdown of the biggest pre-market stock movers worth watching today! Via InvestorPlace Tesla, Nike, Sigilon Therapeutics Among Top Trending Stocks Today June 29, 2023 Via Benzinga Tesla, AMD, Ford, Starbucks, Aurinia Pharma: Why These 5 Stocks Are Drawing Investors' Attention Today May 02, 2023 Via Benzinga 3 Biotechs That Might Get Bought Out in 2023 April 26, 2023 Biotech is expected to be a hotbed of mergers and acquisitions this year. Via The Motley Fool Second Quarter Outlook For Biotech Stocks April 25, 2023 Biotech stocks have been consolidating recently but may be ready to rally higher due to factors such as a declining 10-year yield and growing M&A activity. Via Talk Markets Is Aurinia Pharmaceuticals Up for Grabs? Shareholder Suggests a Quick Sale for a Bigger Payday April 24, 2023 Via Benzinga 3 Stocks That Already Doubled in 2023 and Could Keep Climbing April 11, 2023 The gains these stocks notched in the first few months of the year could be the beginning of a much longer bull run. Via The Motley Fool What's Going On With Aurinia Pharmaceuticals Stock Wednesday? April 05, 2023 Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares are trading higher Wednesday after the company announced "promising results" from its AURORA Via Benzinga What's Going On With Aurinia Pharmaceuticals Stock Today? February 28, 2023 Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) shares are trading higher after the company reported better-than-expected fourth-quarter EPS and sales fig Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
